4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0001209191-15-043034
CEO and Executive Chairman acquired 24,055 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MENDLEIN JOHN CEO and Executive Chairman | 2015-05-12 | Conversion | +24,055 | 245,971 | D | ||
| Derivatives | |||||||
| MENDLEIN JOHN CEO and Executive Chairman | 2015-05-12 | Conversion · Series C Redeemable Convertible Preferred Stock | −170,218 | 0 | D | ||
| MENDLEIN JOHN CEO and Executive Chairman | 2015-05-12 | Conversion · Series D Redeemable Convertible Preferred Stock | −21,122 | 0 | D | ||
Loading xslF345X03/doc4.xml…